Results 121 to 130 of about 15,101 (190)

Molecular entities for the anti-melanoma effect of <i>Solanum nigrum</i>. [PDF]

Bioinformation
Sakharkar N, Kaul-Ghanekar R, Song Y, Yang J.   +3 more
europepmc   +1 more source

Glucosylated cholesterol accumulates in atherosclerotic lesions and impacts macrophage immune response. [PDF]

J Lipid Res
Marques ARA, Ferreira IS, Ribeiro Q, Ferraz MJ, Lopes E, Pinto D, Hall M, Ramalho J, Artola M, Almeida MS, Rodrigues G, Gonçalves PA, Ferreira J, Borbinha C, Marto JP, Viana-Baptista M, Gouveia E Melo R, Pedro LM, Soares MIL, Vaz WLC, Vieira OV, Aerts JMFG.   +21 more
europepmc   +1 more source

GBA2, SCARB2 e PSAP não são modificadores da Doença de Gaucher

, 2018
Rodrigo Tzovenos Starosta, Suélen Porto Basgalupp, Marina Siebert, Ida Vanessa Döederlein Schwartz   +3 more
openalex   +1 more source

Correction: B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2. [PDF]

J Exp Med
du Pré MF, Blazevski J, Dewan AE, Stamnaes J, Kanduri C, Sandve GK, Johannesen MK, Lindstad CB, Hnida K, Fugger L, Melino G, Qiao SW, Sollid LM.   +12 more
europepmc   +1 more source

Cultured Macrophage Models for the Investigation of Lysosomal Glucocerebrosidase and Gaucher Disease. [PDF]

Int J Mol Sci
Louwerse M, Bila KO, van der Lienden MJC, de Beaufort AJM, Boot RG, Artola M, van Eijk M, Aerts JMFG.   +7 more
europepmc   +1 more source

Fluorescence polarisation activity-based protein profiling for the identification of deoxynojirimycin-type inhibitors selective for lysosomal retaining alpha- and beta-glucosidases. [PDF]

Chem Sci, 2023
van der Gracht D, Rowland RJ, Roig-Zamboni V, Ferraz MJ, Louwerse M, Geurink PP, Aerts JMFG, Sulzenbacher G, Davies GJ, Overkleeft HS, Artola M.   +10 more
europepmc   +1 more source

MassIVE MSV000100217 - Effects of GBA2 inhibitor and glucosyl cholesterol on Protein Expression

laraia, Luca
openalex   +1 more source

Precision Target Discovery for Migraine: An Integrated GWAS-eQTL-PheWAS Pipeline. [PDF]

Molecules
Liu X, Liu Q, Zhu H, Zhou X, Li X, Hu M, Peng F, Ji J, Yang S.   +8 more
europepmc   +1 more source

Catalytic properties, functional attributes and industrial applications of β-glucosidases [PDF]

, 2015

core   +1 more source

GBA2-deficiency and the effect on sphingolipid metabolism in hereditary spastic paraplegia type 46

Bi-allelic, pathogenic variants in the GBA2 gene cause hereditary spastic paraplegia subtype 46, complicated by cerebellar ataxia. The GBA2 gene encodes the non-lysosomal ß-glucosidase, also known as GBA2. This enzyme is involved in the sphingolipid metabolism and catalyzes the breakdown of glucosylceramide into glucose and ceramide.
openaire   +3 more sources